Life Technologies Corporation sequence-based system for HLA typing

Thursday, 21 February, 2013 | Supplied by: Life Technologies



Life Technologies Corporation has received US Food and Drug Administration (FDA) 510(k) clearance for its 3500 Dx Genetic Analyzers and SeCore HLA typing kits. The Applied Biosystems 3500 Dx/3500xL Dx CS2 Genetic Analyzers, Invitrogen SeCore HLA Sequencing Kits and uTYPE Dx HLA Sequence Analysis Software constitute the first 510(k)-cleared, sequence-based system for HLA typing in the United States.

Tissue typing is an essential component of determining compatibility between donors and patients for organ and bone marrow transplantation. HLA typing on the 3500 Dx offers labs an optimised, streamlined workflow said to have higher resolution than other molecular HLA typing technologies such as sequence-specific oligonucleotide (SSO) methods.

Online: www.invitrogen.com
Phone: 1800 331 627
Related Products

Thermo Fisher Scientific Ion Torrent CarrierSeq ECS Kit

The Ion Torrent CarrierSeq ECS Kit for the Ion GeneStudio S5 System consolidates a multiplatform...

BTX ECM 2001+ Electrofusion and Electroporation System

The BTX ECM 2001+ Electrofusion and Electroporation System is suitable for improving hybridoma...

Molecular Innovations Human Alpha-1-Antitrypsin Total Antigen ELISA Kit

Molecular Innovations' Human Alpha-1-Antitrypsin ELISA Kit is for the sensitive quantitative...


  • All content Copyright © 2020 Westwick-Farrow Pty Ltd